NanoSphere Health Sciences Inc.

OTC: NSHSF · Healthcare · Biotechnology

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH 9DQ —GM —SS 33

v0.1 · 35/100 weight · pillars only

↑ listing tenure, disclosure history · ↓ Altman-Z, balance-sheet leverage

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$86.3k

Employees

Market cap

$102.8k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02025

Net income-$86.3k-$86.3k2025

Operating income-$181.9k-$181.9k2025

Total assets$16.8k$16.8k2025

Liabilities$1.4M$1.4M2025

Equity-$1.3M-$1.3M2025

Revenue trend

FY2018 – FY2025 · USD

$37.9k

FY18

$218.0k

FY19

FY20

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

NanoSphere Health Sciences Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

SETO Holdings, Inc.54D Kali, Inc.——Many Bright Ideas Technologies Inc.——Black Bird Biotech, Inc.——

Key facts

CEOMichael Alexander Iverson

SectorHealthcare

IndustryBiotechnology

HeadquartersVancouver, BC

ExchangeOTC: NSHSF

Employees3

IPO date2009-10-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.